10-Q: Verano Holdings Reports Q3 Loss Amid Revenue Decline

Verano Holdings Corp. reported a net loss of $43.8 million for Q3 2025, with revenues decreasing 6% due to price compression and wholesale challenges.

Summary

• Net revenues for the three months ended September 30, 2025, decreased by 6% to $202.8 million from $216.7 million in the prior year period.
• Gross profit for Q3 2025 was $95.2 million, down from $109.1 million in Q3 2024, resulting in a gross profit margin of 47% compared to 50% previously.
• Net loss attributable to Verano Holdings Corp. increased to $43.8 million for Q3 2025, up from $42.6 million in Q3 2024.
• Selling, General, and Administrative (SG&A) expenses decreased by 13% to $80.6 million in Q3 2025, representing 40% of revenue, down from 43% in Q3 2024.
• The cultivation (wholesale) segment experienced a 9.4% revenue decrease in Q3 2025, primarily due to price compression and an accounts receivable strategy of holding accounts for non-payment.
• The retail segment saw a modest 0.1% revenue increase in Q3 2025, driven by product availability in Florida, largely offset by targeted promotional activities and discounting.
• For the nine months ended September 30, 2025, net revenues decreased 7% to $614.9 million, and net loss increased to $74.5 million from $69.2 million in the prior year period.
• A loss contingency of $10.0 million was recorded in Q3 2025 related to the settlement of the Vireo litigation.
• An impairment charge of $5.4 million was recorded on a held-for-sale cultivation facility in Pennsylvania during Q3 2025.
• The company entered into a new $75.0 million revolving loan facility, drawing $50.0 million to prepay existing debt under the 2022 Credit Agreement without penalty.
• Shareholders approved a plan of arrangement for the company's continuance from British Columbia, Canada, to Nevada, U.S.

Sentiment

Score: 3

Explanation: The company's financial performance shows significant declines in revenue and gross profit, coupled with increased net losses. While there are positives in SG&A reduction and strategic debt management, these do not fully offset the core business's deteriorating profitability and cash flow from operations. The ongoing federal illegality and market price compression remain substantial headwinds.

Positives

• Selling, General, and Administrative (SG&A) expenses decreased by 13% ($11.8 million) in Q3 2025 compared to Q3 2024, indicating improved cost management.
• SG&A expenses as a percentage of revenue improved to 40% in Q3 2025 from 43% in Q3 2024.
• The retail segment showed a modest revenue increase of 0.1% in Q3 2025, driven by product availability in the Florida market.
• Net cash used in investing activities decreased significantly by $98.2 million for the nine months ended September 30, 2025, primarily due to lower capital expenditures and acquisition activity.
• Net cash used in financing activities decreased by $36.1 million for the nine months ended September 30, 2025, reflecting strategic debt management including proceeds from a new loan and principal repayments.
• The company successfully entered into a new $75.0 million revolving loan facility and used $50.0 million to prepay existing debt without penalty, enhancing financial flexibility.
• Working capital increased by $82.5 million to $242.0 million as of September 30, 2025, driven by increased inventory and a shift in income tax payable to long-term liabilities.
• The Vireo litigation was settled for a total of $10.0 million ($1.0 million cash and $9.0 million asset transfer), resolving a significant legal contingency.

Negatives

• Net revenues decreased by 6% ($13.9 million) for the three months ended September 30, 2025, compared to the prior year period.
• Gross profit declined by 12.7% ($13.9 million) in Q3 2025, with the gross profit margin decreasing to 47% from 50%.
• Net loss attributable to the company increased by $1.3 million in Q3 2025, reaching $43.8 million.
• The cultivation (wholesale) segment experienced a 9.4% revenue decrease in Q3 2025, attributed to price compression and an accounts receivable strategy of holding accounts for non-payment.
• A $10.0 million loss contingency was recorded in Q3 2025 due to the settlement of the Vireo litigation.
• An impairment charge of $5.4 million was recorded on a held-for-sale cultivation facility in Pennsylvania.
• Net cash provided by operating activities decreased by $29.7 million for the nine months ended September 30, 2025, primarily due to increased inventory and income tax payments.
• Total Other Income (Expense), net, increased to $(24.7) million in Q3 2025 from $(13.9) million in Q3 2024, largely due to the loss contingency and a loss on debt extinguishment.

Risks

• The illegality of cannabis under U.S. federal law poses significant risks, including potential fines, penalties, civil asset forfeiture, and criminal charges, despite state-level legalization.
• Regulatory and political changes to U.S. federal, state, and local cannabis laws could materially impact operations.
• Economic uncertainty, including inflation, rising interest rates, and changes in consumer confidence, affects business conditions.
• Outstanding indebtedness and the ability to repay such debt remain a challenge.
• Reliance on key management personnel is a critical operational risk.
• Market acceptance of existing and new products, along with potential returns or recalls, could impact revenue.
• Exposure to growth-related operational and execution risks, particularly with an expansion-by-acquisition strategy.
• The company faces risks related to its ongoing litigation matters, although one significant case has been settled.
• Potential product liability claims could arise from cannabis products.
• The company's property may be subject to civil asset forfeiture due to federal cannabis laws.
• Difficulties in accessing and maintaining banking or financial services due to federal regulations persist.
• The cost and difficulty of complying with disparate state-by-state regulatory schemes are substantial.
• The impact of Section 280E of the Internal Revenue Code of 1986, as amended, limits deductible expenses for cannabis companies, resulting in a higher effective tax rate.

Future Outlook

The company expects to continue to obtain information to assist in determining the fair value of net assets acquired during the measurement period for business combinations. It anticipates that price compression at the cultivation (wholesale) level will be partially offset by operational optimization as its current production capacity has not been fully realized. The company expects to retain additional cash from operations, partly due to its treatment of Section 280E of the Code. It believes internally generated funds and other liquidity sources will be sufficient for working capital, capital expenditures, and other business requirements for at least the next 12 months, with long-term needs potentially met through future debt or equity issuances.

Management Comments

• Our strategy is to vertically integrate as a single cohesive company in multiple states through the consolidation of seed-to-sale cultivating, manufacturing, distributing, and dispensing cannabis brands and products at scale.
• Our model includes geographic diversity by establishing a footprint to allow us to adapt to changes in both industry and market conditions.
• The company's management believes the assumptions underlying the financial statements and accompanying notes are reasonable.

Industry Context

The U.S. cannabis industry operates on a state-by-state basis due to federal illegality, with 40 states plus the District of Columbia and U.S. territories authorizing comprehensive medical cannabis programs, and 24 states plus the District of Columbia and U.S. territories authorizing both medical and adult-use programs. The company operates in 13 states. The industry is characterized by price compression across established markets and intense competition, which has impacted the company's cultivation (wholesale) segment. The company's strategy involves vertical integration and geographic diversity to navigate these market conditions.

Comparison to Industry Standards

• The filing does not provide specific global benchmarks or detailed comparisons to comparable companies, projects, or results within the cannabis industry.

Management Changes

Corporate Governance

Legal Proceedings

• The company reached a comprehensive settlement on October 28, 2025, dismissing all outstanding litigation matters with Vireo Growth Inc. (formerly Goodness Growth Holdings, Inc.) that were pending before the Supreme Court of British Columbia, Canada.
• The settlement consisted of a $1.0 million cash payment and the transfer of a non-operational building, classified as held for sale, valued at $9.0 million, to GGH.

Related Party Transactions

• George Archos, Chairman and CEO, participated as a Lender in the 2022 Credit Agreement, funding $1.0 million of the $350.0 million principal amount.
• The company sold products on a wholesale basis to Americana Dream, LLC and Green Therapy, LLC (social equity licensees, referred to as the LLCs) and two associated entities, totaling $681,000 for Q3 2024 and $2.856 million for 9M 2024. An amount of $552,000 was due from these entities as of December 31, 2024.
• Maria Fragias, an immediate family member of George Archos, was the beneficiary of a trust that held ownership and profit interests in Two Pointo, LLC (which has contractual rights to purchase ownership interests in the LLCs and associated entities). This trust divested all interests in Two Pointo in 2024.
• The company leases real property for a retail dispensary in Aurora, Illinois, from 740 Rte. 59, LLC, in which George Archos holds an indirect 50% ownership interest. Payments were $46,000 for Q3 2025 and $138,000 for 9M 2025.
• The company leases real property for a retail dispensary in Lombard, Illinois, from 783 Butterfield LLC, in which George Archos holds a 50% indirect ownership interest. Payments were $93,000 for Q3 2025 and $278,000 for 9M 2025.
• The company paid Sweed High Tech Holdings, Inc. (point of sale software provider) $2.838 million for services during the nine months ended September 30, 2025. GP Management Group, LLC, an entity beneficially owned and controlled by George Archos, held an ownership interest of less than 1% in Sweed.

Stakeholder Impact

• Shareholders face increased net losses and declining revenues, potentially impacting share price and future returns, though the resolution of significant litigation removes a major uncertainty.
• Creditors benefit from strategic debt management, including prepayments and a new revolving facility, which could improve the company's liquidity profile.
• Employees may experience ongoing operational adjustments as the company seeks efficiencies and optimizes its footprint, as evidenced by reduced salaries and benefits in SG&A.
• Customers in Florida may see improved product availability, while promotional activities indicate efforts to maintain sales volumes amidst competition.
• Suppliers in the cultivation (wholesale) segment may face continued pressure from price compression and the company's accounts receivable strategy.

Next Steps

• Consummate the continuance of the company from British Columbia, Canada, to Nevada, U.S., pending resolution of the strike at the British Columbia Registrar of Companies.
• Continue to monitor and deploy capital cautiously to minimize negative impacts from inflation and economic uncertainty.
• Focus on operational optimization to partially offset price compression at the cultivation (wholesale) level.

Key Dates

Recommendation

While Verano Holdings Corp. reported declining revenues, increased net losses, and reduced operating cash flow, indicating a challenging financial period, there are mitigating factors. The company successfully reduced SG&A expenses, managed its debt effectively by securing a new revolving facility and making prepayments, and resolved a significant litigation matter. The approval of the corporate continuance to Nevada is a strategic move. However, the core business faces persistent headwinds from price compression in the wholesale segment and the inherent risks of federal cannabis illegality. Given the mixed signals—deteriorating top-line and bottom-line performance offset by operational efficiencies and strategic financial/governance moves—a 'hold' recommendation is appropriate. Investors should monitor the impact of the corporate re-domiciliation, the effectiveness of operational optimizations against market pressures, and any developments in federal cannabis legislation.

Keywords

Cannabis, Marijuana, Multi-State Operator, MSO, SEC Filing, 10-Q, Financial Results, Verano Holdings, VRNOF, Cannabis Industry, Cultivation, Retail Dispensary, Wholesale Cannabis, Financial Performance, Earnings Report, Risk Factors, Debt Management, Corporate Governance, Vireo Litigation, Section 280E